Venaxis is a biomedical company in the United States. The company’s research and development activities primarily focus on a human acute appendicitis blood-based test. APPY’s lead product candidate, known as APPY1, is designed to aid in the evaluation of patients presenting signs and symptoms of acute appendicitis for physicians to diagnose acute appendicitis in children and adolescents. APPY is also developing animal health products, including cattle and equine reproduction products. For more information, visit the company’s Web site: http://aspenbiopharma.com

Let us hear your thoughts below: